← Back to Patent Explorer
US4184849A Expired / Lapsed US ⏱️ 0.0 years remaining

Mixed agglutination

Assignee: Bayer Corp
•
Filing: 1977-12-05
•
Granted: 1980-01-22
•
Expires: 1997-12-05
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The presence of antibodies (Ab) and antigens (Ag) in a liquid is detected by mixing the liquid with two different particulate reagents which mutually agglutinate but whose agglutination is inhibited by the particular Ab or Ag under assay. By detecting the extent of agglutination, the presence or absence of the Ab or Ag can be confirmed. By measuring the extent of agglutination or non-agglutination quantitatively, an amount of Ab or Ag can be determined. The particulate reagents preferably comprise latex.

Inventors

  • 👤 Cesar L. Cambiaso
  • 👤 Floris de Steenwinkel
  • 👤 Adrian E. Leek
  • 👤 Pierre L. Masson

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-26 22:16
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/543; G01N33/54313; Y; Y10; Y10S; Y10S436/00; Y10S436/804; Y10S436/805; Y10S436/815; Y10S436/826

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 131 words
A method of assaying a sample containing a particular antigen or antibody constituent of interest, comprising the steps of: (a) forming a mixture of: (i) a first reagent bound with a first carrier; (ii) a second reagent bound with a second carrier of different size than said first carrier; and (iii) a sample containing said particular antigen or antibody constituent of interest; said first and second reagents tending to bind with each other to form a measurable reaction, and said particular constituent tending to bind with one of said reagents and preclude binding thereof with the other of said reagents; (b) incubating said mixture to effect binding between said first reagent, second reagent, and said constituent; and (c) measuring said reaction to determine the amount of said constituent in said sample.
Claim 2
Independent Claim 131 words
A method of assaying a sample containing a particular antigen or antibody constituent of interest, comprising the steps of: (a) forming a mixture of: (i) a first reagent bound with a first carrier; (ii) a second reagent bound with a second carrier of different size than said first carrier; and (iii) a sample containing said particular antigen or antibody constituent of interest; said first and second reagents tending to bind with each other to form a measurable reaction, and said particular constituent tending to bind with one of said reagents and preclude binding thereof with the other of said reagents; (b) incubating said mixture to effect binding between said first reagent, second reagent, and said constituent; and (c) measuring said reaction to determine the amount of said constituent in said sample.
Claim 3
Dependent Claim 26 words
The method according to claim 1, wherein said first and second carriers are different in size from each other by at least a factor of 2.
Claim 4
Dependent Claim 24 words
The method of assaying a sample in accordance with claim 1, wherein said first and second reagents respectively comprise an antigen and an antibody.
Claim 5
Dependent Claim 24 words
The method of assaying a sample in accordance with claim 1, wherein said first and second reagents respectively comprise an antigen-conjugate and an antibody.
Claim 6
Independent Claim 158 words
A method of quantitatively assaying a particular antigen or antibody constituent in a liquid, which comprises: (a) forming a mixture of: (i) a sample of the liquid containing said particular antigen or antibody constituent under assay, (ii) a first reagent carried by a first particulate material, and (iii) a second reagent carried by a second particulate material of different size than said first particulate material, said first reagent being capable of binding with said second reagent to agglutinate said first and second particulate materials, at least the first reagent also being capable of binding with said particular constituent to inhibit the agglutination of said first and second particulate materials, (b) incubating the mixture to allow the said first reagent to bind, on a competitive basis, with said particular constituent and said second reagent, and (c) measuring the agglutination of said first and second particulate materials and thereby determining the amount of said particular constituent present in the sample.
Claim 7
Independent Claim 158 words
A method of quantitatively assaying a particular antigen or antibody constituent in a liquid, which comprises: (a) forming a mixture of: (i) a sample of the liquid containing said particular antigen or antibody constituent under assay, (ii) a first reagent carried by a first particulate material, and (iii) a second reagent carried by a second particulate material of different size than said first particulate material, said first reagent being capable of binding with said second reagent to agglutinate said first and second particulate materials, at least the first reagent also being capable of binding with said particular constituent to inhibit the agglutination of said first and second particulate materials, (b) incubating the mixture to allow the said first reagent to bind, on a competitive basis, with said particular constituent and said second reagent, and (c) measuring the agglutination of said first and second particulate materials and thereby determining the amount of said particular constituent present in the sample.
Claim 8
Dependent Claim 50 words
A method according to claim 5, wherein said particular constituent is an antigen-type substance, and said first reagent is an antibody capable of binding with the antigen-type substance under assay and said second reagent is substantially the same antigen-type substance under assay which is capable of binding with said antibody.
Claim 9
Dependent Claim 45 words
A method according to claim 5, wherein said particular constituent is an antibody, and said first reagent is an antigen-type substance which is capable of binding with said antibody, and the second reagent is an antibody which is capable of binding with said antigen-type substance.
Claim 10
Dependent Claim 23 words
A method according to claim 5, wherein the respective particle size of each of said first and second particulate materials is substantially uniform.
Claim 11
Dependent Claim 19 words
A method according to claim 5, wherein at least one of said first or second particulate materials comprise latex.
Claim 12
Dependent Claim 26 words
A method of assaying a sample in accordance with claim 5, wherein said particular constituent under assay has a molecular weight of less than about 4000.
Claim 13
Dependent Claim 25 words
A method according to claim 6, wherein the particle size of said first particulate material is at least twice that of said second particulate material.
Claim 14
Dependent Claim 35 words
A method according to claim 11, wherein non-agglutinated first particulate materials in the mixture are selectively counted, and wherein in forming step (a) a known amount of first particulate materials are included in the mixture.
Claim 15
Dependent Claim 26 words
A method according to claim 5, wherein in measuring step (c) the extent of agglutination or non-agglutination is determined by counting agglutinated or non-agglutinated particulate materials.
Claim 16
Dependent Claim 23 words
A method according to claim 13, wherein the said count of said particulate materials is effected while they are present in the mixture.
Claim 17
Dependent Claim 16 words
A method according to claim 14, wherein non-agglutinated particulate materials are selectively counted by optical techniques.
Claim 18
Dependent Claim 22 words
A method according to claim 5, wherein, in measuring step (c) the agglutinated particulate materials are separated from the non-agglutinated particulate materials.
Claim 19
Dependent Claim 39 words
A method according to claim 16, wherein either said first particulate material or said second particulate material comprises an identifying label, and the extent of agglutination or non-agglutination is measured by assay of the label in the separated particles.

References Cited (Backward Citations)

US3088875A Cited
US3564089A Cited
US3873683A Cited
US3862302A Cited
CA951242A Cited
US3925541A Cited
US3853987A Cited
US3862303A Cited
US3826613A Cited
US3876504A Cited
US3981982A Cited
DE2615092A1 Cited
US4031117A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-01-21 1983-07-23 1984-01-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-01-21 1987-07-23 1988-01-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-01-21 1991-07-23 1992-01-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag